Table 4.
Stomach | Colorectal | Liver | Lung | Melanoma | Breasta | Cervix | Prostate | |
---|---|---|---|---|---|---|---|---|
(n = 17,848) | (n = 101,402) | (n = 5732) | (n = 72,437) | (n = 70,464) | (n = 88,768) | (n = 8968) | (n = 95,543) | |
Remoteness | SHR (95% CI)b | SHR (95% CI)b | SHR (95% CI)b | SHR (95% CI)b | SHR (95% CI)b | SHR (95% CI)b | SHR (95% CI)b | SHR (95% CI)b |
Major cities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Inner regional | 1.09 (1.04–1.14) | 1.02 (0.99–1.05) | 1.04 (0.95–1.13) | 1.02 (0.99–1.04) | 0.97 (0.92–1.03) | 1.00 (0.96–1.04) | 1.04 (0.93–1.16) | 1.08 (1.05–1.12) |
Outer regional/Remote | 1.15 (1.07–1.24) | 1.12 (1.08–1.17) | 1.08 (0.95–1.24) | 1.02 (0.99–1.06) | 1.09 (1.00–1.19) | 1.04 (0.98–1.10) | 1.24 (1.07–1.43) | 1.10 (1.05–1.16) |
SEIFA quintile | ||||||||
1 (least disadvantaged) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
2 | 0.99 (0.93–1.05) | 1.05 (1.01–1.08) | 1.01 (0.90–1.12) | 1.06 (1.02–1.09) | 1.10 (1.02–1.18) | 1.06 (1.01–1.11) | 0.94 (0.80–1.10) | 1.06 (1.01–1.11) |
3 | 1.01 (0.95–1.07) | 1.06 (1.02–1.10) | 1.07 (0.96–1.18) | 1.08 (1.05–1.12) | 1.13 (1.05–1.22) | 1.12 (1.07–1.18) | 1.10 (0.95–1.27) | 1.08 (1.03–1.13) |
4 | 1.03 (0.97–1.09) | 1.11 (1.07–1.14) | 1.11 (1.00–1.23) | 1.12 (1.09–1.15) | 1.12 (1.04–1.21) | 1.14 (1.09–1.19) | 1.13 (0.98–1.30) | 1.13 (1.08–1.19) |
5 (most disadvantaged) | 1.03 (0.97–1.09) | 1.14 (1.10–1.18) | 1.22 (1.11–1.34) | 1.15 (1.12–1.18) | 1.25 (1.16–1.34) | 1.14 (1.08–1.19) | 1.11 (0.97–1.27) | 1.16 (1.11–1.22) |
Country of birth | ||||||||
Australia | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Other English speaking | 1.00 (0.95–1.06) | 0.97 (0.93–1.00) | 0.89 (0.80–1.00) | 0.98 (0.95–1.00) | 0.94 (0.86–1.03) | 1.00 (0.95–1.04) | 0.83 (0.73–0.94) | 1.03 (0.99–1.08) |
Non-English speaking | 0.87 (0.83–0.91) | 0.92 (0.89–0.95) | 0.84 (0.78–0.90) | 0.88 (0.86–0.90) | 1.26 (1.14–1.39) | 0.98 (0.94–1.02) | 0.82 (0.73–0.92) | 0.93 (0.89–0.97) |
Unknown | 0.49 (0.41–0.58) | 0.32 (0.28–0.36) | 0.35 (0.25–0.50) | 0.48 (0.43–0.53) | 0.03 (0.03–0.04) | 0.27 (0.23–0.32) | 0.14 (0.09–0.22) | 0.13 (0.11–0.15) |
SEIFA Socio-Economic Index for Areas, SHR Sub-hazard ratio, CI Confidence interval; Country of birth categorised into Australia, other English-speaking and non-English speaking countries and unknown
aFemale breast cancers only
bModels adjusted for sex (when appropriate), age, diagnostic period, summary stage and, as appropriate, for remoteness/SEIFA quintile/country of birth